Advertising executives say companies like the format because it’s cheaper than TV and consumers generally feel influencers ...
Many drug companies are expanding into social media, often partnering with patient influencers who post about managing their ...
Advertising executives say companies like the format because it’s cheaper than TV and consumers generally feel influencers ...
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...